Probiotic strains for single or multi-species blends

Information on our probiotic strains

Probi LiveBac® strains are available as a wide variety of formulas such as pure cultures, blends, and finished products. Don't hesitate to contact us for a solution suitable for your needs.

Probiotic strains part of our Livebac® concept

Bifidobacterium longum subsp. infantis (previously known as Bifidobacterium infantis)

B. infantis is commonly found in the human large intestine and is common in infants. B. infantis supports general gut and immune health for infants and children, as well as adults.

Bifidobacterium animalis subsp. lactis (previously known as Bifidobacterium lactis)

B. lactis is commonly found in the human large intestine. B. lactis supports general immune and digestive health.

Lactobacillus casei subsp. casei (previously known as Lacticaseibacillus casei)

L. casei is commonly found in dairy products such as cheese and milk and the human gastrointestinal and urogenital tract. L. casei supports general immune health in children.

Lacticaseibacillus paracasei (previously known as Lactobacillus paracasei)

L. paracasei is naturally present in cheese and milk products as well as the human intestinal tract and mouth. L. paracasei strains are generally good for immune health. The specific strain L. paracasei 8700:2 (DSM 13434), isolated from healthy human colonic mucosa⁶, has been found to promote a balanced and well-nourished microbiota⁷ and enhance the immune system to effectively fight potential pathogens^8-10. It is suitable for infants from 1 year of age, to all throughout adult life.

Lacticaseibacillus rhamnosus (previously known as Lactobacillus rhamnosus)

L. rhamnosus can be found in the gastrointestinal tract and healthy female urogenital tract. L. rhamnosus is the most common Lactobacilli in healthy breast-fed children^1-3. In general, L. rhamnosus strains can support immune and digestive health, as well as protect against urogenital infections. The specific strain L. rhamnosus 271 (DSM 6594) has been isolated from healthy human colonic mucosa⁴. L. rhamnosus 271 has been proven safe and well-tolerated in infants from 11 days of age⁵ and can support gastrointestinal and immune health in infants and children.

Lactilactobacillus sakei (previously known as Lactobacillus sakei)

L. sakei can be found in fermented meat and vegetable products. In general, L. sakei supports immune health.

Lactiplantibacillus plantarum (previously known as Lactobacillus plantarum)

L. plantarum has been consumed for centuries since it frequently occurs in lactic acid- fermented foods such as sauerkraut and kimchi. It is naturally found in the human gastrointestinal tract. In general, L. plantarum strains support gastrointestinal health. The specific strain L. plantarum 6595 (DSM 6595) has been isolated from healthy human colonic mucosa⁴. L. plantarum 6595 has been found to promote a healthy gut in diverse populations and to promote general health and immunity in sensitive groups^11-15.

Lactococcus lactis subsp. lactis (previously known as Lactococcus lactis)

L. lactis can be found in cheese, kefir, and fermented vegetables. In general, L. lactis is good for lactic acid production and is extensively used in the dairy industry. L. lactis supports general immune and gut health.

Limosilactobacillus fermentum (previously known as Lactobacillus fermentum)

L. fermentum is commonly found in fermented foods such as sourdough as well as the human gastrointestinal tract. In general, L. fermentum can help lower cholesterol levels and has antimicrobial and immune strengthening effects.

Limosilactobacillus reuteri (previously known as Lactobacillus reuteri)

L. reuteri is found in the gastrointestinal tract. In general, L. reuteri has been shown to improve gastrointestinal health and support oral and vaginal health.

References

Yang et al. 2016, The infant microbiome: Implications for health and neurocognitive development. Nurs Res 65:76-88.
Palmer et al. 2007, Development of the human infant intestinal microbiota. Plos Biol 7:e177.
Ahrné et al. 2005, Lactobacilli in the intestinal micorbiota of Swedish infants. Microbes Infect 7:1256-1262.
Molin et al, 1993. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J Appl. Bacteriol. 74:314-323.
Önning et al, (2022). New Lactiplantibacillus plantarum and Lacticaseibacillus rhamnosus strains: well tolerated and improve infant microbiota. Pediatric research, 91(7), 1849–1857
Ahrné et al, 1998. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J. Appl. Microbiol. 85:88-94.
Makras et al, 2005. Lactobacillus paracasei subsp paracasei 8700:2 degrades inulin-type fructans exhibiting different degrees of polymerization. App. Environm. Microbiol 71:6531-6537.
Rask et al, 2013. Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli. Clin Exp Immunol. 172:321-332
Ohlsson et al, 2014. Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS ONE 9(3):e92368
Lavasani et al, 2010. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 5(2):1-11.
Oudhuis et al, 2010. Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Int. Care Med. 37:110-117.
Olah et al, 2002. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 89:1103-1107.
Rayes et al, 2002a. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18:609-615.
Rayes et al, 2002b. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 15:123-127
Klarin et al, 2008. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit. Care 12:R136.